{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:33:38Z","timestamp":1790084018132,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd006318.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000}}],"reference-count":85,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006318.pub4","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T07:00:29Z","timestamp":1604905229000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Maintenance agonist treatments for opiate-dependent pregnant women"],"prefix":"10.1002","volume":"2020","author":[{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Lazio Regional Health Service; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Amato","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Lazio Regional Health Service; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayesteh","family":"Jahanfar","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Population and Public Health; University of British Columbia; Vancouver Canada"},{"name":"School of Health Sciences; Central Michigan University; Mount Pleasant Michigan USA"},{"name":"MPH Program, School of Public Health; Central Michigan University; Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bellisario","sequence":"additional","affiliation":[{"name":"CPO Piemonte, Dipartimento Interaziendale di Prevenzione Secondaria dei Tumori S.C. Epidemiologia dei Tumori; AO Citt\u00e0 della Salute e della Scienza di Torino Via San Francesco da Paola 31; Torino Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Ferri","sequence":"additional","affiliation":[{"name":"Best practices, knowledge exchange and economic issues; European Monitoring Centre for Drugs and Drug Addiction; Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Davoli","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Lazio Regional Health Service; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1360-0443.1999.9422317.x","article-title":"Comparison of methadone and slow-release morphine maintenance in pregnant addicts","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD006318.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome","volume":"79","author":"Jones","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1002\/14651858.CD006318.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/ntr\/nts274","article-title":"A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine","volume":"15","author":"Chisolm","year":"2013","journal-title":"Nicotine Tobacco Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006318.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1360-0443.2012.04040.x","article-title":"Neonatal neurobehavior effects following buprenorphine versus methadone exposure","volume":"107","author":"Coyle","year":"2012","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006318.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1360-0443.2012.04039.x","article-title":"Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates","volume":"107","author":"Gaalema","year":"2012","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006318.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1360-0443.2012.04042.x","article-title":"Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine","volume":"107","author":"Holbrook","year":"2012","journal-title":"Addiction"},{"issue":"0","key":"10.1002\/14651858.CD006318.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2013.02.031","article-title":"Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention","volume":"132","author":"Holbrook","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine","volume":"33","author":"Jansson","year":"2011","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","article-title":"Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy","volume":"134","author":"Jones","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006318.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1360-0443.2012.04036.x","article-title":"Maternal Opioid Treatment: Human Experimental Research (MOTHER) - approach, issues and lessons learned","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ntt.2013.05.003","article-title":"The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations","author":"Jones","year":"2013","journal-title":"Neurotoxicology and Teratology"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0013|cit13","unstructured":"Jones HE Johnson RE Jasinski DR Tuten M Milio L Dosing pre to postpartum with either buprenorphine or methadone 69th Annual Scientific Meeting of the College on Problems of Drug Dependence Quebec City, Canada 2007 16 21"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/ADM.0b013e31815ca2c6","article-title":"Dosing adjustments in postpartum patients maintained on buprenorphine or methadone","volume":"2","author":"Jones","year":"2008","journal-title":"Journal of Addiction Medicine"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","article-title":"Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes","volume":"185","author":"Kaltenbach","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD006318.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.genm.2011.10.001","article-title":"Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?","volume":"8","author":"Unger","year":"2011","journal-title":"Gender Medicine"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0018|cit18","unstructured":"Wilson-Murphy MM Chisolm MS Leoutsakos JS Kaltenbach K Heil SH Martin PR Treatment completion in opioid-dependent pregnant patients randomised to agonist treatment: the role of intravenous drug use 73rd Annual Scientific Meeting of the College on Problems of Drug Dependence 2011 195, Abstract no: 778"},{"issue":"1","key":"10.1002\/14651858.CD006318.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hup.2275","article-title":"Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women","volume":"28","author":"Winklbaur-Hausknost","year":"2013","journal-title":"Human Psychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006318.pub4-BIB0020|cit20","first-page":"1","article-title":"Maternal Opioid Treatment: Human Experimental Research (MOTHER) study: maternal, fetal and neonatal outcomes from secondary analyses","volume":"107","author":"Emmalee","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD006318.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ebmh.10.3.88","article-title":"Dihydrocodeine as effective as methadone for maintenance of treatment for opiate dependence?","volume":"10","author":"Bell","year":"2007","journal-title":"Evidence Based Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD006318.pub4-BIB0022|cit22","first-page":"80","article-title":"Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department","volume":"29","author":"Binder","year":"2008","journal-title":"Neuro Endocrinology Letters"},{"issue":"1","key":"10.1002\/14651858.CD006318.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1521-0391.1995.tb00259.x","article-title":"Improving treatment outcome in pregnant, methadone-maintained women","volume":"4","author":"Carroll","year":"1995","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2019.105888","article-title":"A pilot multisite study of patient navigation for pregnant women with opioid use disorder","volume":"87","author":"Cochran","year":"2019","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD006318.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jsat.2006.10.003","article-title":"Reducing potential for child abuse among methadone-maintained parents: results from a randomized controlled trial","volume":"32","author":"Dawe","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drugalcdep.2006.08.024","article-title":"Management of neonatal abstinence syndrome in neonates born to opioid maintained women","volume":"87","author":"Ebner","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000052040","article-title":"Buprenorphine maintenance in pregnant opiate addicts","volume":"1","author":"Fisher","year":"1998","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0028|cit28","unstructured":"Gordon AL Stacey H Pearson V Haslam RR Lopatko OV White JM Buprenorphine and methadone in pregnancy: effects on the mother and fetus\/neonate Sixty-Sixth Annual Scientific Meeting of the College on Problems of Drug Dependence 2004"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijgo.2003.10.001","article-title":"Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user","volume":"85","author":"Hulse","year":"2004","journal-title":"International Journal of Gynaecology & Obstetrics"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/adc.2003.033555","article-title":"A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome","volume":"89","author":"Jackson","year":"2004","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"3","key":"10.1002\/14651858.CD006318.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependent pregnant women: clinical and research issues","volume":"35","author":"Jones","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1002\/14651858.CD006318.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1521-0391.2011.00119.x","article-title":"Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment","volume":"20","author":"Jones","year":"2011","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0033|cit33","unstructured":"Keyser-Marcus L Miles D Jansson L Jones H Svikis D Perinatal opiate dependence: methadone and birth outcomes Drug and Alcohol Dependence 2002"},{"issue":"10","key":"10.1002\/14651858.CD006318.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00228-011-1049-9","article-title":"Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study","volume":"67","author":"Lacroix","year":"2011","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD006318.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0740-5472(96)00006-2","article-title":"Predictors of prenatal substance use and birth weight during outpatient treatment","volume":"14","author":"Laken","year":"1997","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0036|cit36","first-page":"S35","article-title":"Opioid dependence during pregnancy: balancing risk versus benefit","volume":"21","author":"Martin","year":"2011","journal-title":"Klinik Psikofarmakoloji B\u00fclteni"},{"issue":"3","key":"10.1002\/14651858.CD006318.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"250; author rep","DOI":"10.1080\/10550490902786892","article-title":"Response to \"Methadone maintenance vs. methadone taper during pregnancy\" paper","volume":"18","author":"Newman","year":"2009","journal-title":"American Journal on Addictions"},{"issue":"6","key":"10.1002\/14651858.CD006318.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/00952990903374080","article-title":"Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study","volume":"35","author":"Stine","year":"2009","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1002\/14651858.CD006318.pub4-BIB0039|cit39","first-page":"1","article-title":"Parental control, parental warmth, and psychosocial adjustment in a sample of substance-abusing mothers and their school-aged and adolescent children","volume":"32","author":"Suchman","journal-title":"2007"},{"issue":"4","key":"10.1002\/14651858.CD006318.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/00952990.2011.643977","article-title":"Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women","volume":"38","author":"Tuten","year":"2012","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0041|cit41","unstructured":"Opioid dependence treatment therapies in pregnancy clinicaltrials.gov\/show\/NCT03098407"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0042|cit42","unstructured":"Australian Institute of Health and Welfare National Drug Strategy Household Survey detailed report 2010. Canberra: Australian Institute of Health and Welfare www.aihw.gov.au\/reports\/illicit-use-of-drugs\/2010-ndshs\/contents\/table-of-contents"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0043|cit43","unstructured":"Australian Institute of Health and Welfare National Drug Strategy Household Survey detailed report 2013 www.aihw.gov.au\/reports\/illicit-use-of-drugs\/2013-ndshs-detailed\/contents\/table-of-contents"},{"issue":"10","key":"10.1002\/14651858.CD006318.pub4-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004147.pub4","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1542\/peds.2012-3931","article-title":"Prenatal substance abuse: short- and long-term effects on the exposed fetus","volume":"131","author":"Behnke","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002210","article-title":"LAAM maintenance vs methadone maintenance for heroin dependence","author":"Clark","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0047|cit47","unstructured":"Center for Substance Abuse Treatment Medication-assisted treatment for opioid addiction in opioid treatment programs. (Treatment Improvement Protocol Series 43) www.ncbi. nlm.nih.gov 2005"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0048|cit48","first-page":"179","article-title":"Substance abuse in pregnancy","volume":"14","author":"Dattel","year":"1990","journal-title":"Seminars in Perinatology"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0049|cit49","unstructured":"Dunlop AJ Panjari M O'Sullivan H Henschke P Clinical guidelines for the use of buprenorphine in pregnancy Turning Point Alcohol and Drug Centre, Fitzroy, Australia 2003"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0051|cit51","volume-title":"EMCDDA Papers","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2014"},{"issue":"3","key":"10.1002\/14651858.CD006318.pub4-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2005.08.010","article-title":"Pregnancy outcome in women who use opiates","volume":"126","author":"Fajemirokun-Odudeyi","year":"2006","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"12","key":"10.1002\/14651858.CD006318.pub4-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003410.pub4","article-title":"Heroin maintenance for chronic heroin-dependent individuals","author":"Ferri","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0055|cit55","volume-title":"Primary Pediatric Care","author":"Finnegan","year":"1992"},{"issue":"31","key":"10.1002\/14651858.CD006318.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0057|cit57","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"11","key":"10.1002\/14651858.CD006318.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/j.1360-0443.1997.tb02877.x","article-title":"The relationship between maternal use of heroin and methadone and infant birth weight","volume":"92","author":"Hulse","year":"1997","journal-title":"Addiction"},{"issue":"7","key":"10.1002\/14651858.CD006318.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1360-0443.1998.93710338.x","article-title":"The relationship between maternal opiate use and neonatal mortality","volume":"93","author":"Hulse","year":"1998","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/02791072.1994.10472263","article-title":"Methadone treatment during pregnancy","volume":"26","author":"Jarvis","year":"1994","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","article-title":"Use of buprenorphine in pregnancy: patient management and effects on the neonate","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006318.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy: effects and management","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ADM.0000000000000308","article-title":"Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance","volume":"11","author":"Klaman","year":"2017","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006318.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution","volume":"82","author":"Lejuene","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD006318.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1479-828X.2004.00221.x","article-title":"Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse","volume":"44","author":"Ludlow","year":"2004","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD006318.pub4-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006318.pub4-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006318.pub4-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004330.pub2","article-title":"Psychosocial treatment for opiate abuse and dependence","author":"Mayet","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006318.pub4-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001333.pub4","article-title":"Oral naltrexone maintenance treatment for opioid dependence","author":"Minozzi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0071|cit71","unstructured":"National Institute of Drug Abuse Monitoring the future: treating opioid use disorder during pregnancy www.drugabuse.gov\/publications\/treating-opioid-use-disorder-during-pregnancy"},{"issue":"22","key":"10.1002\/14651858.CD006318.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.280.22.1936","article-title":"Effective medical treatment of opiate addiction","volume":"280","author":"National Institutes of Health Consensus Development Panel","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0073|cit73","volume-title":"National Drug Control Strategy","author":"Office of National Drug Control Policy","year":"2020"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0074|cit74","unstructured":"Ordean A Opioid agonist treatment during pregnancy: review of methadone and buprenorphine Best Start Resource Centre Annual Conference; 2018 February 7 en.beststart.org\/2018-bsrc-conference-handouts 2018"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ajog.2004.06.082","article-title":"Pharmacotherapy for pregnant women with addiction","volume":"191","author":"Rayburn","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD006318.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","article-title":"Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American Congress of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0077|cit77","unstructured":"Schunemann H Brozek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0078|cit78","unstructured":"Department of Health (England) Drug Misuse and Dependence: UK Guidelines on Clinical Management www.smmgp.org.uk 2007"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0079|cit79","unstructured":"World Drug Report 2018 www.unodc.org\/wdr2018\/"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1552-6909.1999.tb02170.x","article-title":"Methadone treatment during pregnancy","volume":"28","author":"Wang","year":"1999","journal-title":"Journal of Obstetric, Gynecologic, and Neonatal Nursing"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"197s","DOI":"10.1097\/01.AOG.0000533261.35229.25","article-title":"Opioid detoxification during pregnancy: systematic review and meta-analysis of maternal and neonatal outcomes","volume":"131","author":"Wang","year":"2018","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0082|cit82","volume-title":"Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy","author":"World Health Organization","year":"2014"},{"issue":"9","key":"10.1002\/14651858.CD006318.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1360-0443.2008.02283.x","article-title":"Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates","volume":"103","author":"Winklbaur","year":"2008","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD006318.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"11","author":"Zedler","year":"2016","journal-title":"Addiction"},{"issue":"12","key":"10.1002\/14651858.CD006318.pub4-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006318.pub3","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","author":"Minozzi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:47:12Z","timestamp":1694648832000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006318.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":85,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006318.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]}}}